HETTY HIRSHMAN: Open Payments
NPI 1245272889 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 64 payments from 8 companies in 2025. Trend: 2023 $1,504 · 2024 $764 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $213 |
| Neurocrine BioSciences, Inc. | 17 | $207 |
| Alkermes, Inc. | 9 | $152 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: VRAYLAR, INGREZZA, ARISTADA, AUSTEDO XR, CAPLYTA, COBENFY, HETLIOZ, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
